Kneat Inc. allows regulated organizations to move from paper-based validation to intelligent, digitized, and paperless solutions. They provide expert, up-to-date, in-depth, and reliable knowledge and services about easy implementation of GMP solutions. Numus coordinated the public listing of Kneat on the TSX-CV via a reverse takeover. Since the public listing, Numus has coordinated multiple private placements for the company. Since going public, Kneat has raised over $60mil and the the software was onboarded by 8 of the top 10 largest pharmaceutical companies globally.